Insight Conference
Professor of Clinical Pharmacology and Internal Medicine

Prof. Dr. Matthias Liechti

University Hospital, Basel

Matthias Liechti is a professor for clinical pharmacology and internal medicine at the University Hospital Basel. With his psychopharmacology research group at the Departments of Biomedicine and Clinical Research, Matthias Liechti investigates the pharmacology of psychoactive substances both in vitro and in humans. The group is best known for the work on the acute effects of MDMA (ecstasy) and LSD in humans. The team characterizes the pharmacology of the constantly emerging novel psychoactive substances (designer drugs) using in vitro methods. In experimental clinical studies Matthias Liechti investigates the clinical pharmacology of psychostimulants, MDMA, LSD, psilocybin and mescaline. The team also conducts Pharmaco-fMRI studies in collaboration with the Department of Psychiatry. Further, the group has initiated phase 2 studies with LSD in patients with cluster headache, major depression, and anxiety disorder in collaboration with the respective disease specialists.


Panel II: Building the Mental Health Treatments of the Future – Between Neurobiological Effects and Phenomenological Diversity

Moderated by: View Event

Pharmacology and Acute Effects of Different Psychedelics

Current clinical trials with psychedelics mostly use psilocybin. However, there are other classic…

View Event

Conference Presentations

INSIGHT 2019: Current Research on LSD in Healthy Subjects and Patients
Symposium of Swiss Medical Association for Psycholytic Therapy 2015: New experimental human research with LSD

Insight Newsletter

Sign up to our newsletters and we’ll keep you up to date with everything to do with INSIGHT.